Amitell Capital’s Protagonist Therapeutics PTGX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,129	Closed	-$397K	–	27
2022 Q2	$397K	Hold	50,129	–	–	0.9%	15
2022 Q1	$1.19M	Buy	+50,129	New	+$1.19M	0.69%	44